| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |